DVAX
Price
$11.00
Change
+$0.15 (+1.38%)
Updated
Sep 27 closing price
32 days until earnings call
IRWD
Price
$4.02
Change
-$0.04 (-0.99%)
Updated
Sep 27 closing price
32 days until earnings call
Ad is loading...

DVAX vs IRWD

Header iconDVAX vs IRWD Comparison
Open Charts DVAX vs IRWDBanner chart's image
Dynavax Technologies
Price$11.00
Change+$0.15 (+1.38%)
Volume$954.64K
CapitalizationN/A
Ironwood Pharmaceuticals
Price$4.02
Change-$0.04 (-0.99%)
Volume$975.1K
CapitalizationN/A
View a ticker or compare two or three
DVAX vs IRWD Comparison Chart
Loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IRWD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DVAX vs. IRWD commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a Hold and IRWD is a Hold.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (DVAX: $10.88 vs. IRWD: $4.98)
Brand notoriety: DVAX and IRWD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DVAX: 95% vs. IRWD: 69%
Market capitalization -- DVAX: $1.62B vs. IRWD: $1.36B
DVAX [@Pharmaceuticals: Other] is valued at $1.62B. IRWD’s [@Pharmaceuticals: Other] market capitalization is $1.36B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVAX’s FA Score shows that 1 FA rating(s) are green whileIRWD’s FA Score has 0 green FA rating(s).

  • DVAX’s FA Score: 1 green, 4 red.
  • IRWD’s FA Score: 0 green, 5 red.
According to our system of comparison, DVAX is a better buy in the long-term than IRWD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DVAX’s TA Score shows that 5 TA indicator(s) are bullish while IRWD’s TA Score has 4 bullish TA indicator(s).

  • DVAX’s TA Score: 5 bullish, 2 bearish.
  • IRWD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DVAX is a better buy in the short-term than IRWD.

Price Growth

DVAX (@Pharmaceuticals: Other) experienced а -2.94% price change this week, while IRWD (@Pharmaceuticals: Other) price change was +1.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.57%. For the same industry, the average monthly price growth was +1.93%, and the average quarterly price growth was +40.52%.

Reported Earning Dates

DVAX is expected to report earnings on Oct 31, 2024.

IRWD is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+0.57% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVAX($1.62B) has a higher market cap than IRWD($1.36B). DVAX has higher P/E ratio than IRWD: DVAX (31.63) vs IRWD (10.31). DVAX YTD gains are higher at: -22.175 vs. IRWD (-56.469). DVAX has higher annual earnings (EBITDA): 9.67M vs. IRWD (-924.84M). DVAX has more cash in the bank: 742M vs. IRWD (92.2M). DVAX has less debt than IRWD: DVAX (257M) vs IRWD (716M). IRWD has higher revenues than DVAX: IRWD (443M) vs DVAX (232M).
DVAXIRWDDVAX / IRWD
Capitalization1.62B1.36B119%
EBITDA9.67M-924.84M-1%
Gain YTD-22.175-56.46939%
P/E Ratio31.6310.31307%
Revenue232M443M52%
Total Cash742M92.2M805%
Total Debt257M716M36%
FUNDAMENTALS RATINGS
DVAX vs IRWD: Fundamental Ratings
DVAX
IRWD
OUTLOOK RATING
1..100
1667
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
46100
SMR RATING
1..100
90100
PRICE GROWTH RATING
1..100
5794
P/E GROWTH RATING
1..100
440
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRWD's Valuation (76) in the Pharmaceuticals Other industry is in the same range as DVAX (84) in the Biotechnology industry. This means that IRWD’s stock grew similarly to DVAX’s over the last 12 months.

DVAX's Profit vs Risk Rating (46) in the Biotechnology industry is somewhat better than the same rating for IRWD (100) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew somewhat faster than IRWD’s over the last 12 months.

DVAX's SMR Rating (90) in the Biotechnology industry is in the same range as IRWD (100) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew similarly to IRWD’s over the last 12 months.

DVAX's Price Growth Rating (57) in the Biotechnology industry is somewhat better than the same rating for IRWD (94) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew somewhat faster than IRWD’s over the last 12 months.

DVAX's P/E Growth Rating (4) in the Biotechnology industry is somewhat better than the same rating for IRWD (40) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew somewhat faster than IRWD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DVAXIRWD
RSI
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Stochastic
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Momentum
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
MACD
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
TrendWeek
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Advances
ODDS (%)
Bullish Trend about 2 months ago
0%
N/A
Declines
ODDS (%)
Bearish Trend about 2 months ago
0%
Bearish Trend about 2 months ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend about 1 month ago
0%
Aroon
ODDS (%)
N/A
Bullish Trend about 1 month ago
0%
View a ticker or compare two or three
Ad is loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IRWD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

DVAX and

Correlation & Price change

A.I.dvisor tells us that DVAX and PETQ have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DVAX and PETQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
-3.03%
PETQ - DVAX
32%
Poorly correlated
-0.07%
SUPN - DVAX
28%
Poorly correlated
-1.28%
VTRS - DVAX
27%
Poorly correlated
-1.57%
AMPH - DVAX
27%
Poorly correlated
-3.61%
IRWD - DVAX
25%
Poorly correlated
-1.58%
More

IRWD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRWD has been loosely correlated with AMPH. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if IRWD jumps, then AMPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
-1.58%
AMPH - IRWD
37%
Loosely correlated
-3.61%
DVAX - IRWD
22%
Poorly correlated
-3.03%
PBH - IRWD
21%
Poorly correlated
-0.74%
NBIX - IRWD
21%
Poorly correlated
-1.54%
VTRS - IRWD
20%
Poorly correlated
-1.57%
More